These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4984047)

  • 1. Clonidine (Catapres): a new antihypertensive agent.
    Khan A; Camel G; Perry HM
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 3. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with a new anti-hypertensive agent (St 155)].
    Vettore L
    Minerva Med; 1972 Apr; 63(29):1669-78. PubMed ID: 5025774
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of catapres, a new hypotensive drug: a preliminary report.
    Ng J; McGrgor DD; Taylor KM; Smirk H
    N Z Med J; 1967 Dec; 66(425):864-70. PubMed ID: 5236015
    [No Abstract]   [Full Text] [Related]  

  • 8. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with the new antihypertensive agent Catapresan].
    Messerich J
    Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
    Villalpando J; Skromme D; Chávez B; Serrano P
    Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
    Brunner H; Djawan S; Dorda W; Penner E; Grabner G
    Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and hemodynamic study of a new antihypertensive agent].
    Palmero HA; Caeiro AE; Lussi H; Massari P; Amuchastegui S
    Prensa Med Argent; 1968 Aug; 55(25):1212-6. PubMed ID: 4885121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double blind study with clomidine and reserpine in ambulant therapy of hypertension].
    Dorscheid HO; Ehinger U; Förster W; Hempel J; Kondziella W; Schulz G; Schulz J; Sziegoleit W; Wolf R
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1017-20. PubMed ID: 4557762
    [No Abstract]   [Full Text] [Related]  

  • 16. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 17. [Catapresan--a new hypotensive agent].
    Tarkowska A
    Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
    Sung PK; Samet P; Yeh BK
    Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study.
    Schachter M; Mitchell G; Niziol C; Abhyankar BA
    Int J Clin Pract; 2003; 57(6):479-82. PubMed ID: 12918886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.